10-K: Health In Tech Reports Profitable Growth in 2024, Focuses on AI and Strategic Expansion

Health In Tech's 2024 10-K filing highlights a profitable year with a 2% revenue increase, driven by strategic shifts and AI-powered platforms.

Summary

• Health In Tech (HIT) is an insurance technology platform aiming to streamline healthcare processes through vertical integration, simplification, and automation.
• The company operates a health insurance marketplace where insurance companies list stop-loss policies for self-funded benefits plans.
• Licensed brokers can use HIT's platform to obtain bindable quotes and sell customized health benefits plans to small businesses.
• HIT's revenue increased by 2% year-over-year, with a strategic shift towards A-rated insurance policies and AI-assisted underwriting for mid-sized businesses.
• As of December 31, 2024, HIT had clients in 41 states, serving 890 business clients with 18,348 employees.
• The company completed its Initial Public Offering (IPO) on December 24, 2024, raising $9.2 million before deducting underwriting discounts and commissions.
• HIT is investing in AI-backed technology, including its eDIYBS platform, to improve efficiency and transparency in the underwriting process.
• The company faces risks related to cybersecurity, data privacy, regulatory compliance, and competition in the insurance services technology industry.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there's revenue growth and strategic expansion, there are also concerning decreases in key financial metrics and reliance on third-party AI, creating a balanced but cautious outlook.

Positives

• HIT's AI-powered platforms aim to deliver efficiency, availability, and security features.
• The company has growing distribution channels with 417 brokers, 11 TPAs, and 212 additional third-party agencies registered on its platforms.
• HIT has a dedicated management team with extensive industry experience.
• The company has proprietary technology and data that improve efficiency and transparency.
• The company has three registered trademarks, one patent, and one pending patent application.
• The company has implemented an Artificial Intelligence Governance Policy to establish a framework for the ethical and responsible use of AI technologies within the company.

Negatives

• The number of EEs billed decreased by 14% from 2023 to 2024.
• Revenues from underwriting modeling decreased by 19.2% for the year ended December 31, 2024, compared to the same period in 2023.
• Cost of revenues increased to 20.8% of revenue for the year ended December 31, 2024, from 12.0% for the same period in 2023.
• Adjusted EBITDA decreased by $2.5 million to $2.3 million for the year ended December 31, 2024, from $4.8 million for the year ended December 31, 2023.
• The company relies on third-party AI technology, which could lead to errors in risk assessment and potential biases.
• The company's management team has limited experience managing a public company.

Risks

• The company's success depends on retaining and expanding its network of brokers, TPAs, MGUs, and other third-party agents.
• Failure to accurately perform underwriting actuarial reviews could negatively impact the reputation of the eDIYBS platform.
• A decrease in the number of members utilizing the company's platforms could lead to a decrease in revenue.
• The company relies on the health of the U.S. health insurance industry and benefits of self-insurance plans.
• Failure to comply with applicable privacy, security, and data laws could materially and adversely affect the company.
• The company's limited operating history makes it difficult to evaluate its current business performance and future prospects.
• The company is subject to risks associated with outsourcing services and functions to third parties.
• Cyber-attacks or data security breaches could disrupt the company's information systems and operations.
• The company's Class A Common Stock price may be volatile or may decline regardless of its operating performance.
• The dual class structure of the company's common stock concentrates voting control with the CEO and CFO.

Future Outlook

The company intends to continue investing and scaling to address the needs of small-and medium-sized businesses and expand its distribution to medium sized business employers with over 150 employees.

Industry Context

The insurance services technology industry is characterized by rapid technological evolution, significant competition, and strong defense of intellectual property.

Comparison to Industry Standards

• The document mentions competitors like ServiceNow, Phreesia, Inc, and Everquote.
• The document states that two of Health In Tech's competitors require two weeks to produce a quote, while another competitor can provide an initial quote within minutes, but that quote is contingent upon receiving all health applications.
• Health In Tech's eDIYBS platform provides bindable quotes in about two minutes, unless the platform raises certain unknown risk flags that require further manual review via a health application completed by the employee and manually reviewed by an underwriter.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not party to any material legal proceedings.

Related Party Transactions

• In 2023, the company received $18,242 from a related party, which was the advanced expense payment made for the related party in 2022.

Stakeholder Impact

• The company's performance and strategic decisions can impact shareholders, employees, customers, suppliers, and creditors.
• The company's focus on AI and technology innovation may lead to improved services and cost savings for customers.
• The company's growth strategy and financial performance can affect employee opportunities and job security.

Next Steps

• Attract more TPAs, MGUs, and brokers to use the company's platforms.
• Introduce ancillary products that expand the company's offerings.
• Monetize the company's platforms.

Key Dates